|
20 Feb 2026 |
SIS
|
Consensus Share Price Target
|
301.75 |
423.25 |
- |
40.27 |
buy
|
|
|
|
|
30 Jan 2026
|
SIS
|
Motilal Oswal
|
301.75
|
400.00
|
336.50
(-10.33%)
|
32.56 |
Buy
|
|
|
SIS’s (SECIS) 3QFY26 revenue was up 24.5% YoY/11.4% QoQ at INR41.8b vs. our estimate of INR40.3b. Revenue growth was aided by ~23% growth in India Security, whereas International Security/Facilities Management posted a growth of 1.5%(CC)/1.0% QoQ.
|
|
06 Nov 2025
|
SIS
|
Motilal Oswal
|
301.75
|
410.00
|
339.40
(-11.09%)
|
35.87 |
Buy
|
|
|
SIS (SECIS)’s 2QFY26 revenue was up 15% YoY/5.9% QoQ at INR37.6b vs. our estimate of INR35.6b. Revenue growth was aided by ~5.7% growth in India security, whereas International Security/Facilities management posted a growth of 1.9%(CC)/5.9% QoQ.
|
|
31 Jul 2025
|
SIS
|
Motilal Oswal
|
301.75
|
450.00
|
386.40
(-21.91%)
|
49.13 |
Buy
|
|
|
SIS (SECIS)’s 1QFY26 revenue was up 13.4% YoY/3.5% QoQ at INR35.4b vs. our estimate of INR34.5b. Revenue growth was aided by 18.9% YoY CC growth in Facility Management, whereas India Security/International Security posted 9.2%/12.1% growth YoY.
|
|
05 May 2025
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
361.00
|
325.35
(-7.25%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
01 May 2025
|
SIS
|
Motilal Oswal
|
301.75
|
400.00
|
337.50
(-10.59%)
|
Target met |
Buy
|
|
|
SIS (SECIS)’s 4QFY25 revenue was up 9.3% YoY/1.9% QoQ at INR34.27b, largely in line with our estimate of INR34.6b. Revenue growth was aided by 12.9% YoY growth in Facility management, whereas India Security/International security posted 9.6%/7.7% growth YoY.
|
|
30 Jan 2025
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
414.00
|
330.80
(-8.78%)
|
|
Buy
|
|
|
Quarterly Update Q3FY25
|
|
31 Oct 2024
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
483.00
|
402.00
(-24.94%)
|
|
Buy
|
|
|
Quarterly Update Q2FY25
|
|
30 Oct 2024
|
SIS
|
Axis Direct
|
301.75
|
540.00
|
400.85
(-24.72%)
|
|
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock
|
|
29 Oct 2024
|
SIS
|
Motilal Oswal
|
301.75
|
480.00
|
386.05
(-21.84%)
|
|
Buy
|
|
|
SIS (SECIS)’s 2QFY25 revenue was up 6.3% YoY/4.4% QoQ at INR32.68b, largely in line with our estimate of INR34.51b.
|
|
29 Jul 2024
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
585.00
|
421.25
(-28.37%)
|
|
Buy
|
|
|
Quarterly Update Q1FY25
|
|
26 Jul 2024
|
SIS
|
Axis Direct
|
301.75
|
540.00
|
419.75
(-28.11%)
|
|
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
06 May 2024
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
441.00
|
440.50
(-31.50%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY24
|
|
03 May 2024
|
SIS
|
Axis Direct
|
301.75
|
540.00
|
455.15
(-33.70%)
|
|
Buy
|
|
|
Recommendation: Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
01 Feb 2024
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
741.00
|
488.50
(-38.23%)
|
|
Buy
|
|
|
Quarterly Update Q3FY24
|
|
01 Feb 2024
|
SIS
|
Axis Direct
|
301.75
|
540.00
|
488.50
(-38.23%)
|
|
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
01 Nov 2023
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
794.00
|
429.40
(-29.73%)
|
|
Buy
|
|
|
Quarterly Update Q2FY24
|
|
01 Nov 2023
|
SIS
|
Axis Direct
|
301.75
|
475.00
|
429.40
(-29.73%)
|
Target met |
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
21 Sep 2023
|
SIS
|
Keynote Capitals Ltd
|
301.75
|
837.00
|
426.10
(-29.18%)
|
|
Buy
|
|
|
Initiating Coverage Report
|
|
28 Jul 2023
|
SIS
|
Axis Direct
|
301.75
|
475.00
|
434.65
(-30.58%)
|
Target met |
Buy
|
|
|
Recommendation: Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
05 May 2023
|
SIS
|
Axis Direct
|
301.75
|
425.00
|
383.35
(-21.29%)
|
Target met |
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|